Loading...
Apria, Inc.
APR•NASDAQ
Healthcare
Medical - Instruments & Supplies
$37.50
$0.00(0.00%)

The company's financials show resilient growth, with revenue advancing from $275.27M in Q1 2021 to $296.52M in Q4 2021. Gross profit remained healthy with margins at 70% in Q4 2021 compared to 68% in Q1 2021. Operating income hit $24.39M last quarter, sustaining a consistent 8% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $52.95M. Net income dropped to $17.74M, while earnings per share reached $0.50. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan